to date, no studies have investigated the role of dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs in SIH or SID
Available from: Liao C, Liang X, Zhang X, Li Y (2023) The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis
GLP-1 Compounded Medications Targeted by Connecticut Attorney General On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications
Physical activity guidelines: UK Chief Medical Officers' report
PlexusDx eliminates this uncertainty with direct-pay semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan, available nationwide without insurance